Cointime

Bridge Medicines

company

About

Bridge Medicines is a drug discovery company

  • 11 - 50

Highlights

Total Funding Amount
$10M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series Unknown
Industries
Pharmaceutical
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

Bridge Medicines is a drug discovery company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management. Bridge Medicines is a groundbreaking initiative that completes an unbroken, fully funded and professionally staffed path from concept to drug candidate, to develop efficiently and quickly innovative therapeutics for the treatment of human diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$10M
Bridge Medicines has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on Nov 13, 2020 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 13, 2020 Series Unknown $10M 1 — — Detail
Oct 31, 2016 Series Unknown — 1 Takeda — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Bridge Medicines is funded by 1 investors. Takeda are the most recent investors.
Investor Name Lead Investor Funding Round
Takeda — Series Unknown
Cointime
เนื้อหา
บริษัท